Pour le traitement de lobsit et du surpoids avec facteur de risque, la dose maximale de Wegovy est de 7,2 mg par semaine , aprs une augmentation progressive de 20 semaines selon le protocole standard, mais elle peut tre ajuste selon la tolrance au traitement
Similar findings were also reported in a JAMA article
Thus, in BD type 1, serotonin reuptake inhibitors (SSRIs) and bupropion associated with lithium, divalproex or an atypical antipsychotic are reasonable options, while serotonin norepinephrine reuptake inhibitors (SNRIs) and monoamine oxidase inhibitors (MAOIs) have a have higher propensity to induce manic switch and to produce mood destabilization
Once opened, use within 90 days
Long term weight health is about more than medication persistenceit's about helping each person navigate their unique journey, said Thomas Tsang, MD, MPH, Chief Medical Officer at Omada Health
2021;162(4):bqab017